|

Incidence and Clinical Features of Breakthrough Pain After Brachial Plexus Block in Diabetic Patients

RECRUITINGSponsored by Second Hospital of Shanxi Medical University
Actively Recruiting
SponsorSecond Hospital of Shanxi Medical University
Started2025-09-20
Est. completion2026-09-20
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

This observational study aims to determine the incidence and clinical characteristics of rebound-breakthrough pain after ultrasound-guided brachial plexus block in adult patients with type 2 diabetes mellitus. Adult patients undergoing elective upper-extremity surgery are divided into a type 2 diabetes group and a non-diabetic control group. Baseline clinical data and pain-related outcomes are collected after nerve block. This work may provide evidence for optimizing perioperative pain management for diabetic patients receiving brachial plexus block.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Aged 18 years or older
* Undergoing elective upper-extremity surgery
* Planned for ultrasound-guided brachial plexus block with 0.375% ropivacaine
* Able to cooperate with pain assessment and follow-up within 48 hours after block
* Written informed consent obtained

Exclusion Criteria:

* Allergy or contraindication to amide-type local anesthetics
* Pre-existing peripheral neuropathy of the affected upper limb
* Chronic regular use of opioids before surgery
* Coagulopathy or infection at the block puncture site
* Cognitive dysfunction unable to complete NRS pain evaluation
* Pregnancy or lactation
* Incomplete clinical data expected during follow-up

Conditions2

DiabetesPostoperative Pain

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.